Metformin
Biguanide- Drug Class
- Biguanide
- Mechanism of Action (MOA)
- ↓ hepatic gluconeogenesis and ↑ peripheral insulin sensitivity (does not stimulate insulin secretion).
- Black Box Warning
- Lactic acidosis — risk rises with renal or hepatic impairment, age ≥65, iodinated contrast, hypoxic states, alcohol.
- Clinical Notes
- First-line for type 2 DM; weight-neutral, no hypoglycemia as monotherapy. GI upset, lowers vitamin B12. Hold for iodinated contrast.
- Source
- FDA label
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
Used for
Same family
Got a pharmacology lecture that covers Metformin? Turn it into flashcards and board-style questions, free. Drop it on the home page
All pharmacology